Your browser doesn't support javascript.
loading
Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema.
Shimizu, Norihiro; Oshitari, Toshiyuki; Tatsumi, Tomoaki; Takatsuna, Yoko; Arai, Miyuki; Sato, Eiju; Baba, Takayuki; Yamamoto, Shuichi.
Affiliation
  • Shimizu N; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Oshitari T; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Tatsumi T; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Takatsuna Y; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Arai M; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Sato E; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Baba T; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Yamamoto S; Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, Japan.
Biomed Res Int ; 2017: 1747108, 2017.
Article in En | MEDLINE | ID: mdl-28758110
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Macular Edema / Receptors, Vascular Endothelial Growth Factor / Diabetic Retinopathy / Ranibizumab Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Biomed Res Int Year: 2017 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Macular Edema / Receptors, Vascular Endothelial Growth Factor / Diabetic Retinopathy / Ranibizumab Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Biomed Res Int Year: 2017 Document type: Article Affiliation country: Japan